The abstract is read at the publisher; the summary is JClub's.
Cell-cycle regulatory perturbations in retinal degeneration likely reflect distinct, state-dependent biological programs across retinal cell types, with neuronal re-entry remaining incompletely evidenced.
- Why it matters: The stakes are that pathway changes are often interpreted as neuronal cell-cycle re-entry, but proliferative competence differs between terminal neurons and other retinal populations.
- What they did: This review synthesizes evidence across inherited retinal diseases, AMD, DR, retinal gliosis and inflammation, and retinal organoid models, proposing an evidence hierarchy and a fate-bifurcation model.
- The result: It argues many reports lack sufficient support for bona fide neuronal cell-cycle re-entry, and that outcome depends on cell-cycle engagement depth/duration plus checkpoint integrity, CDK inhibitor activity, DNA damage, metabolism, and microenvironment cues.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.